Fundraising FoxLumira Ventures — 2026 Investments
3 investments dated 2026 · listed companies and verified rows first · show all
Contraline develops new contraceptive and reproductive health technologies, with a focus on male contraception.
BiotechDigital HealthMedical DevicesCharlottesville, US
Kevin Eisenfrats(Founder)inJohn Herr(Founder)
BoardIris Van Alderwerelt van Rosenburgh(Director)Gurdane Bhutani(Director)inMartin J Emerson(Director)Tom Thorpe(Director)
Co-investorsBiotechnology Value FundMBX CapitalAllied Venture PartnersAlumni VenturesAmboy Street VenturesAurum Venture Partners+19 more
Nervonik develops peripheral nerve stimulation (PNS) systems designed for high-motion, dynamic activity, using a patented technology that adds biosensing and objective feedback to neuromodulation.
HardwareHealthtechMedical Devices
Co-investorsFoothill VenturesJoyance PartnersShangBay Capital LLCUS Venture PartnersAmzak HealthU.S. Venture Partners
SoundBlade Medical develops handheld histotripsy technology for non-invasive surgery, using focused ultrasound to treat tissue with precision.
HardwareHealthtechMedical Devices
Jeremy Brown(Co-Founder & CTO)inMatt Mallay(Co-Founder & Sr. Dir. R&D)inAndre Bezanson(Co-Founder & Dir. R&D)inEli Vlaisavljevich(Co-Founder)inRick Balys(Co-Founder)inNeil Barman(Chief Executive Officer)in
Co-investorsAmzak HealthAPERTURE Venture PartnersInvest Nova Scotia
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.